- Case report
- Open Access
Mesenteric desmoid tumor of the interposed jejunal pouch after total gastrectomy
© Tamura et al; licensee BioMed Central Ltd. 2006
Received: 13 December 2005
Accepted: 01 June 2006
Published: 01 June 2006
Desmoid tumor is a rare entity, and most desmoid tumors are located in abdominal wall or extra-abdominal tissues. Occurrence of desmoid tumor in mesentry is extremely rare.
we report a mesenteric desmoid tumor in a 73-years-old woman who had undergone total gastrectomy reconstructed with jejunal pouch interposition for gastric carcinoma. After 1 year, a tumor was originating from mesentery of the interposed jejunal pouch was identified, and the patient underwent resection of the large mass which was found to invade pancreas. Histological examination revealed desmoid tumor.
Desmoid tumor is rare, and it was difficult for the differential diagnosis of desmoid tumor or recurrent tumor.
Desmoid is derived from the Greek word "desmos", meaning band-like. The tumors are defined as benign fibrous tissue tumors arising in the musculoaponeurotic structures throughout the body. There is no report of metastasis for desmoid tumor, however, desmoid tumor sometimes shows locally invasive growth . Histological examination usually shows uniformed mature fibroblasts in both size and shape without karyomitosis . An annual incidence of desmoid is rare, and it is reported only in 2–4 cases per 1 million populations . Moreover, desmoid tumors commonly occur as an extracolonic manifestation of familial adenomatous polyposis (FAP), especially Gardner syndrome . There is no report of intra-abdominal desmoid tumor after total gastrectomy, originating from the interposed jejunal pouch.
She is presently doing well and has no sign of any recurrent tumor 4 years after the operation.
Surgical trauma, which is one of the most important etiologic factors for desmoid, can induce desmoid growth . However, desmoid tumor originating from the jejunal pouch, which had been interposed for reconstruction after total gastrectomy for improvement of early postoperative eating capacity, body weight and quality of life has not been reported before. The desmoid tumor originated from mesentery of reconstructed jejunal pouch, which has not been affected surgical manipulation. Although anastomotic leakage, abscess, wound infection, and fistula are the known complications of total gastrectomy, occurrence of desmoid tumor is rare . In our case, there were no postoperative complications, and there was no intra-abdominal inflammatory lesion that could have led to formation of desmoid tumor.
Mesenteric desmoid tumor is rare and has few symptoms associated with this tumor, thus it is difficult to diagnose these lesions early. In this case identification of a solid mass at the intra-abdominal site after total gastrectomy, possibility of a tumor recurrence was first considered and later was considered as a solitary recurrent lymph node metastasis, the diagnosis of desmoid was never considered. Surgery is the treatment of choice for desmoid tumors.
The incidence of recurrence is reported to be 40%, with surgical excision alone the recurrence rate of 77% in mesenteric desmoid tumors have been reported . Surgical margin has been reported as an important factor for the recurrence of desmoid, the 10-year recurrence rate for the patients with negative surgical margins is reported to be 27%, whereas it is 54% for patients with positive surgical margins . Use of adjuvant radiotherapy has improved relapse rate for the patients with positive surgical margins and unresectable desmoid tumors . It is suggested that if surgical resection is not possible due to some reason the patients should be treated by radiotherapy.
A significant 3.5-fold increased risk for the development of desmoid tumors among females has been reported, particularly during or after pregnancy [4, 10]. An increased risk for the female gender is consistent with the observation that desmoid cells may express estrogen receptors and are inhibited in their in vitro proliferation by antiestrogen compounds . Tamoxifen has antiestrogen activity and it is possible to be effective in desmoid tumors .
The dogma prevalent in medical oncology has been that low-grade tumors with no known metastatic potential do not kill patients and may not respond to chemotherapy [12, 13]. In this case, the patient was kept on observation alone as i) the surgical margin was negative and ii) advanced age of the patient. However, it was demonstrated that desmoid tumors respond to chemotherapy. Surgery was planned in this case as gastric cancer was early stage, and the recurrence are rare. If the gastric cancer had been advanced stage to begin with, we might have planned chemotherapy with the diagnosis of recurrent gastric cancer.
The desmoid tumor originating from the mesentry of the jejunal pouch after total gastrectomy has not been reported. It was a surprise, as desmoid tumor is rare and it was difficult to think of desmoid tumor as differential diagnosis.
Written consent of the patient was obtained for publication of his case report.
- Naylor EW, Gardner EJ, Richards RC: Desmoid tumors and mesenteric fibromatosis in Gardner's syndrome:report of kidred 109. Arch Surg. 1979, 114: 1181-1185.View ArticlePubMedGoogle Scholar
- Anika H, Claudia A, Tilmann V, Andreas U, Gabriela M: High-dose tamoxifen and sulindac as fiest-line treatment for desmoid tumors. Cancer. 2004, 100: 612-620. 10.1002/cncr.11937.View ArticleGoogle Scholar
- Reitamo JJ, Hayry P, Nykyri E, Saxen E: The desmoid tumor. Incidence, sex, age and anatomical distribution in the Finnish population. Am J Clin Pathol. 1982, 77: 665-673.PubMedGoogle Scholar
- Rodriguez-Bigas MA, Mahoney MC, Karakousis CP, Petrelli NJ: Desmoid tumors in patients with familial adenomatous polyposis. Cancer. 1994, 74: 1270-1274. 10.1002/1097-0142(19940815)74:4<1270::AID-CNCR2820740415>3.0.CO;2-7.View ArticlePubMedGoogle Scholar
- Japanese Gastric Cancer Association: Japanese Classification of Gastric Carcinoma. 1998, Tokyo: Kanehara & Co., Ltd., 2Google Scholar
- Friedl W, Caspari R, Sengteller R, Uhlhaas S, Lamberti C, Jungck M, Kadmon M, Wolf M, Fahnenstich J, Gebert J, Moslein G, Mangold E, Propping P: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis ? Experience from 680 FAP families. Gut. 2001, 48: 515-521. 10.1136/gut.48.4.515.PubMed CentralView ArticlePubMedGoogle Scholar
- Smith JW, Shiu MH, Kelsey L: Morbidity of radical lymphadenectomy in the curative resection of gastric carcinoma. Arch Surg. 1981, 126: 1469-1473.View ArticleGoogle Scholar
- Easter DW, Halasz NA: Recent trends in the management of desmoid tumors. Summary of 19 cases and review of the literature. Ann Surg. 1989, 210: 765-769.PubMed CentralView ArticlePubMedGoogle Scholar
- Ballo MT, Zagars GK, Pollack A: Desmoid tumor: prognostic factors and outcome after surgery, radiation therapy, or combined surgery and radiation therapy. J Clin Oncol. 1999, 17: 158-167.PubMedGoogle Scholar
- Clark SK, Phillips RK: Desmoids in familial adenomatous polyposis. Br J Surg. 1996, 83: 1494-1504.View ArticlePubMedGoogle Scholar
- Lim CL, Walker MJ, Mehta RR, Das Gupta TK: Estrogen and antiestrogen binding sites in desmoid tumors. Eur J Cancer Clin Oncol. 1986, 22: 583-587. 10.1016/0277-5379(86)90047-7.View ArticlePubMedGoogle Scholar
- Patel SR, Benjamin RS: Desmoid tumors respond to chemotherapy: deflying the dogma in oncology. J Clin Oncol. 2006, 24: 11-12. 10.1200/JCO.2005.03.6566.View ArticlePubMedGoogle Scholar
- Papagelopoulos PJ, Mavrogenis AF, Mitsiokapa EA, Papaparaskeva KTH, Galanis EC, Soucacos PN: Current trends in the management of extra-abdominal desmoid tumours. World J Surg Oncol. 2006,Google Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.